<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2017 Workiva-->
<!--r:6f9d426d-7cdf-4d24-852c-1304a591467b,g:9b882308-6c8b-47b4-823c-512a5c520540-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="cpix-20180331.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/DocumentandEntityInformation" xlink:type="extended" id="i0053f23ae3a0427f9740572d64575af9_2f5ed007-667b-4302-b4ee-e84a0487ab62"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cpix-20180331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i92d2ef0c43b04ee8af13c254ef353b3d_0e93c7e0-c8c5-4cce-868f-d9aa1179f91b"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="cpix-20180331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended" id="i6692810f31c64a52a1218bd731c9bb29_08aa5cca-3a6c-40c2-9bfd-9c1d7c2e6651"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveIncomeLossUnaudited" xlink:type="simple" xlink:href="cpix-20180331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveIncomeLossUnaudited"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveIncomeLossUnaudited" xlink:type="extended" id="ia606cdecae32425d9e7ad06d8fb0dce4_472aedfa-3111-4124-96d2-22e1667c5a6b"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="cpix-20180331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended" id="i3b0143e2c0a648f4a85338837e5585f8_07dfb4f1-4b24-4ce6-a3d9-89d7053e3404"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/CondensedConsolidatedStatementofEquityUnaudited" xlink:type="simple" xlink:href="cpix-20180331.xsd#CondensedConsolidatedStatementofEquityUnaudited"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/CondensedConsolidatedStatementofEquityUnaudited" xlink:type="extended" id="id4cc4b1507a64e2f9b657c7434245762_c2533a7a-3e1a-4dce-bb25-d2afc8b1301f">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0c948b4d-e048-4456-b767-fa1ea6089b66" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7b399b50-c422-4f10-8a21-864dd183cc26" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0c948b4d-e048-4456-b767-fa1ea6089b66" xlink:to="loc_us-gaap_StatementTable_7b399b50-c422-4f10-8a21-864dd183cc26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0ab30c2d-47a1-4688-a400-dac7902b39a6" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7b399b50-c422-4f10-8a21-864dd183cc26" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0ab30c2d-47a1-4688-a400-dac7902b39a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3965654f-0d17-41fc-93db-005b2e1e8326_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0ab30c2d-47a1-4688-a400-dac7902b39a6" xlink:to="loc_us-gaap_EquityComponentDomain_3965654f-0d17-41fc-93db-005b2e1e8326_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3965654f-0d17-41fc-93db-005b2e1e8326" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0ab30c2d-47a1-4688-a400-dac7902b39a6" xlink:to="loc_us-gaap_EquityComponentDomain_3965654f-0d17-41fc-93db-005b2e1e8326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_adc7178c-caf1-4f52-b5b6-3cd980ddc18d" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3965654f-0d17-41fc-93db-005b2e1e8326" xlink:to="loc_us-gaap_CommonStockMember_adc7178c-caf1-4f52-b5b6-3cd980ddc18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_bbcff47a-a10a-4efa-81eb-f55f4385dbe7" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3965654f-0d17-41fc-93db-005b2e1e8326" xlink:to="loc_us-gaap_RetainedEarningsMember_bbcff47a-a10a-4efa-81eb-f55f4385dbe7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_d6fa5a67-3ee5-40c8-9394-b4d600e0255d" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3965654f-0d17-41fc-93db-005b2e1e8326" xlink:to="loc_us-gaap_NoncontrollingInterestMember_d6fa5a67-3ee5-40c8-9394-b4d600e0255d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0c948b4d-e048-4456-b767-fa1ea6089b66" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_81c5a663-0f02-455c-9cc0-4b74fd1b0096" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_81c5a663-0f02-455c-9cc0-4b74fd1b0096" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_19d9be05-476a-4bb7-978a-57f87a618b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_19d9be05-476a-4bb7-978a-57f87a618b4e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6c56f8cd-e5f5-43bb-a6b8-4815a61cc4ff" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_6c56f8cd-e5f5-43bb-a6b8-4815a61cc4ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_79408b8c-74ec-4768-b938-c50355f6db99" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_79408b8c-74ec-4768-b938-c50355f6db99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2f88c0f9-69c1-4357-90da-21a1943e2db8" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2f88c0f9-69c1-4357-90da-21a1943e2db8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_72736815-fe3b-48db-b51e-85bc8fe46deb" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_72736815-fe3b-48db-b51e-85bc8fe46deb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_f0ffe988-cf84-4794-972e-1b68a68c8e84" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_f0ffe988-cf84-4794-972e-1b68a68c8e84" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_c721872b-ea53-4efa-9040-fb115edc32be" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_c721872b-ea53-4efa-9040-fb115edc32be" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1977eca3-303e-415a-a3a7-2fefb61b8bbc" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_02fd07eb-3483-412f-be0b-5fa109f70d13" xlink:to="loc_us-gaap_ProfitLoss_1977eca3-303e-415a-a3a7-2fefb61b8bbc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_df240e3c-b679-423c-8f18-ede9e7a67d5c" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_365e2bcf-405d-42a1-a70c-6b79665147c2" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/OrganizationandBasisofPresentation" xlink:type="simple" xlink:href="cpix-20180331.xsd#OrganizationandBasisofPresentation"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/OrganizationandBasisofPresentation" xlink:type="extended" id="i2685eb44a7224e3ab9ff684a5411044d_6d705c5e-54fa-4264-bc6f-ae04912ba0c2"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies" xlink:type="simple" xlink:href="cpix-20180331.xsd#OrganizationandBasisofPresentationPolicies"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/OrganizationandBasisofPresentationPolicies" xlink:type="extended" id="i6b77309833cb403d87d017ba2ffbafcb_a2016f73-5015-4a0a-a2c4-4c4ce270ec09"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/OrganizationandBasisofPresentationOrganizationDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#OrganizationandBasisofPresentationOrganizationDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/OrganizationandBasisofPresentationOrganizationDetails" xlink:type="extended" id="ib67eaf6455ac41819972edd83f259211_630aadc5-f825-45ba-8200-97ca1d20a396"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/MarketableSecurities" xlink:type="simple" xlink:href="cpix-20180331.xsd#MarketableSecurities"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/MarketableSecurities" xlink:type="extended" id="i889ade827762413bbbae4bc253b02fcc_6ff37859-990d-4cd5-982c-29720f4f3892"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/MarketableSecuritiesTables" xlink:type="simple" xlink:href="cpix-20180331.xsd#MarketableSecuritiesTables"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/MarketableSecuritiesTables" xlink:type="extended" id="if9c31097e1254bc19c355cc76bc9b828_ebe9ee4d-017f-42ca-90bc-1f14fd196264"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/MarketableSecuritiesDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#MarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/MarketableSecuritiesDetails" xlink:type="extended" id="i30825be48e524171b968a78e505a84cd_eda54e22-fa98-488d-b29e-78e0149989be">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_97ae5a12-59d4-457d-9759-ceb6d9ee866c" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_81ce91e8-e514-4a7f-b7e6-58383f5d83b8" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_97ae5a12-59d4-457d-9759-ceb6d9ee866c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_81ce91e8-e514-4a7f-b7e6-58383f5d83b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_06c9ee86-655d-4e62-8243-ef392bf93f6d" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_81ce91e8-e514-4a7f-b7e6-58383f5d83b8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_06c9ee86-655d-4e62-8243-ef392bf93f6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f15f0f57-9512-44b8-8131-564405612d23_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_06c9ee86-655d-4e62-8243-ef392bf93f6d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f15f0f57-9512-44b8-8131-564405612d23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f15f0f57-9512-44b8-8131-564405612d23" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_06c9ee86-655d-4e62-8243-ef392bf93f6d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f15f0f57-9512-44b8-8131-564405612d23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_923cd94c-83d8-4b5c-8a99-04bf33ef2b04" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f15f0f57-9512-44b8-8131-564405612d23" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_923cd94c-83d8-4b5c-8a99-04bf33ef2b04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_097a9cb5-8b8f-4275-ae50-f65b7fe24151" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f15f0f57-9512-44b8-8131-564405612d23" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_097a9cb5-8b8f-4275-ae50-f65b7fe24151" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_12d5a003-c360-4343-b4ee-c9bc4f017ea8" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_81ce91e8-e514-4a7f-b7e6-58383f5d83b8" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_12d5a003-c360-4343-b4ee-c9bc4f017ea8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_12d5a003-c360-4343-b4ee-c9bc4f017ea8" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_12d5a003-c360-4343-b4ee-c9bc4f017ea8" xlink:to="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_UsTreasuryNotesAndBondsSecuritiesDomain_515c6707-1dc8-456e-b185-dce74003568c" xlink:href="cpix-20180331.xsd#cpix_UsTreasuryNotesAndBondsSecuritiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf" xlink:to="loc_cpix_UsTreasuryNotesAndBondsSecuritiesDomain_515c6707-1dc8-456e-b185-dce74003568c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_e6dfd279-9807-4504-b660-515ad2ed1b75" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByPrivateEnterprisesMember_e6dfd279-9807-4504-b660-515ad2ed1b75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AgencySecuritiesMember_1990a339-b8bb-42f7-8be0-4581c959bd89" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AgencySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf" xlink:to="loc_us-gaap_AgencySecuritiesMember_1990a339-b8bb-42f7-8be0-4581c959bd89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_38aaffec-2567-4ffe-b769-99287ff4b84f" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_38aaffec-2567-4ffe-b769-99287ff4b84f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_LoanPoolsMember_e35b8638-4e27-4f7c-8b69-5ec2139bd0d7" xlink:href="cpix-20180331.xsd#cpix_LoanPoolsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf" xlink:to="loc_cpix_LoanPoolsMember_e35b8638-4e27-4f7c-8b69-5ec2139bd0d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_4e2bc80f-0e00-43f8-8a8a-28e54d7137f5" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_d624c7fa-3f16-4726-a2c5-2bfb910ef2bf" xlink:to="loc_us-gaap_MunicipalBondsMember_4e2bc80f-0e00-43f8-8a8a-28e54d7137f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_c60cc649-b5c3-4292-9564-350eff5e1db2" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_97ae5a12-59d4-457d-9759-ceb6d9ee866c" xlink:to="loc_us-gaap_TradingSecurities_c60cc649-b5c3-4292-9564-350eff5e1db2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="cpix-20180331.xsd#EarningsLossPerShare"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/EarningsLossPerShare" xlink:type="extended" id="i0089c9c0943742b8877c667067468860_4a749619-4326-42c6-8768-7631e34d3fdb"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="cpix-20180331.xsd#EarningsLossPerShareTables"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/EarningsLossPerShareTables" xlink:type="extended" id="ie6fb5d7ebe364f52af088d29a66b1bfe_923fd1db-aa42-4314-a210-708bb9db79a4"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/EarningsLossPerShareDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#EarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/EarningsLossPerShareDetails" xlink:type="extended" id="ia4f8629b969e420cad658ae81cd14544_e5fda1da-d954-4bb4-82b2-d025488ea588"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/EarningsLossPerShareTextualDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#EarningsLossPerShareTextualDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/EarningsLossPerShareTextualDetails" xlink:type="extended" id="i667a446ab4644316a3bf0d1783acb513_b929d2bd-893e-41fc-88e7-c2dd4a9c1403"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/Revenues" xlink:type="simple" xlink:href="cpix-20180331.xsd#Revenues"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/Revenues" xlink:type="extended" id="ic7b922b5f0114daab42d2c3e65bf8f45_fedcb292-9e9e-4b87-aa00-f80cb18fb9ab"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/RevenuesTables" xlink:type="simple" xlink:href="cpix-20180331.xsd#RevenuesTables"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/RevenuesTables" xlink:type="extended" id="i922b43e8e4fd4b0b855058d603ecceff_9443d600-d819-4cfe-8622-05e5864ac5fd"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/RevenuesDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#RevenuesDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/RevenuesDetails" xlink:type="extended" id="ie8c659151d97421482c4efb3fdac098f_cda144a0-af4d-4276-b448-e2f157b2218e">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_79e085ea-10ed-40a8-a901-5f503324e123" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_77ff7643-7443-4c5b-b736-9267286a5d06" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_79e085ea-10ed-40a8-a901-5f503324e123" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_77ff7643-7443-4c5b-b736-9267286a5d06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductOrServiceAxis_542fcd1a-8fb0-4a45-bab7-d2ea5df0acc3" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_77ff7643-7443-4c5b-b736-9267286a5d06" xlink:to="loc_us-gaap_ProductOrServiceAxis_542fcd1a-8fb0-4a45-bab7-d2ea5df0acc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ProductOrServiceAxis_542fcd1a-8fb0-4a45-bab7-d2ea5df0acc3" xlink:to="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ProductOrServiceAxis_542fcd1a-8fb0-4a45-bab7-d2ea5df0acc3" xlink:to="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_AcetadoteMember_113d4fcc-1adc-4d0e-a665-db9e9b052dd6" xlink:href="cpix-20180331.xsd#cpix_AcetadoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:to="loc_cpix_AcetadoteMember_113d4fcc-1adc-4d0e-a665-db9e9b052dd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_OmeclamoxPakMember_abc35174-9082-45f6-accb-aecda112e178" xlink:href="cpix-20180331.xsd#cpix_OmeclamoxPakMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:to="loc_cpix_OmeclamoxPakMember_abc35174-9082-45f6-accb-aecda112e178" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_KristaloseMember_44af31b2-29d8-4266-9fd8-9832fca53b96" xlink:href="cpix-20180331.xsd#cpix_KristaloseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:to="loc_cpix_KristaloseMember_44af31b2-29d8-4266-9fd8-9832fca53b96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_VaprisolMember_bd415d69-5c86-4c24-868b-c8f60300a829" xlink:href="cpix-20180331.xsd#cpix_VaprisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:to="loc_cpix_VaprisolMember_bd415d69-5c86-4c24-868b-c8f60300a829" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_CaldolorMember_d8fb8d41-385a-4a02-bb2b-6270dc8f5742" xlink:href="cpix-20180331.xsd#cpix_CaldolorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:to="loc_cpix_CaldolorMember_d8fb8d41-385a-4a02-bb2b-6270dc8f5742" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_EthyolMember_a365d9cc-2a9c-4350-b2c0-7effb013c4c8" xlink:href="cpix-20180331.xsd#cpix_EthyolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:to="loc_cpix_EthyolMember_a365d9cc-2a9c-4350-b2c0-7effb013c4c8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_TotectMember_581ef155-f4e4-4456-8995-e1a07e61a706" xlink:href="cpix-20180331.xsd#cpix_TotectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:to="loc_cpix_TotectMember_581ef155-f4e4-4456-8995-e1a07e61a706" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_OtherProductsMember_b186bddd-506d-47c6-ae9c-012c93c850a2" xlink:href="cpix-20180331.xsd#cpix_OtherProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:to="loc_cpix_OtherProductsMember_b186bddd-506d-47c6-ae9c-012c93c850a2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_GenericAcetadoteMember_f2896de5-5e81-4c3e-90ee-9f9f35d8d064" xlink:href="cpix-20180331.xsd#cpix_GenericAcetadoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductsAndServicesDomain_eef6ec60-cb55-4279-8dd7-0e7f02d06074" xlink:to="loc_cpix_GenericAcetadoteMember_f2896de5-5e81-4c3e-90ee-9f9f35d8d064" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetAbstract_0babf943-0e82-4e7e-8379-088b9af98945" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_79e085ea-10ed-40a8-a901-5f503324e123" xlink:to="loc_us-gaap_SalesRevenueNetAbstract_0babf943-0e82-4e7e-8379-088b9af98945" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_ProductsAbstract_113458a4-de40-450b-ae6a-7e214fa3b9e5" xlink:href="cpix-20180331.xsd#cpix_ProductsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SalesRevenueNetAbstract_0babf943-0e82-4e7e-8379-088b9af98945" xlink:to="loc_cpix_ProductsAbstract_113458a4-de40-450b-ae6a-7e214fa3b9e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNet_3c8743cd-0729-4994-bf85-c1cd99e4a1b5" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ProductsAbstract_113458a4-de40-450b-ae6a-7e214fa3b9e5" xlink:to="loc_us-gaap_SalesRevenueNet_3c8743cd-0729-4994-bf85-c1cd99e4a1b5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/Inventories" xlink:type="simple" xlink:href="cpix-20180331.xsd#Inventories"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/Inventories" xlink:type="extended" id="i7e85d955affb43fdb6fe86c729aeedbb_6bcefdd0-9f62-4f24-b30b-2bcb34cc4719"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/InventoriesTables" xlink:type="simple" xlink:href="cpix-20180331.xsd#InventoriesTables"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/InventoriesTables" xlink:type="extended" id="ibf55654a6f33477cae12a3ed31d01639_5c678f17-8b2f-4bec-b305-aab6d861d095"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/InventoriesDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#InventoriesDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/InventoriesDetails" xlink:type="extended" id="if91142f1dd034160a4d7336174b7bcb4_512a0447-559e-4926-beae-2720e58508a9"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/InventoriesTextualDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#InventoriesTextualDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/InventoriesTextualDetails" xlink:type="extended" id="i2d02fd3c15484fc689b852373ad2d316_e1b2ad98-e499-496d-a64e-a6b2cc953f00"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/ShareholdersEquityandDebt" xlink:type="simple" xlink:href="cpix-20180331.xsd#ShareholdersEquityandDebt"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/ShareholdersEquityandDebt" xlink:type="extended" id="if205a3676f824daa81f72954551aefbf_d95d78b7-5bae-48ec-9473-fb28845f1662"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#ShareholdersEquityandDebtShareholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/ShareholdersEquityandDebtShareholdersEquityDetails" xlink:type="extended" id="i46012cf7f115480a8734c6c923e27d04_51a38d12-2ef2-4146-86e8-072a337d362a">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bab5ea3f-f87b-4314-b745-de41113dab1a" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf7e8e59-9a84-473f-8291-18d21630e795" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bab5ea3f-f87b-4314-b745-de41113dab1a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf7e8e59-9a84-473f-8291-18d21630e795" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a3b1beb5-ef39-46c3-9cc0-3af7d9146ece" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf7e8e59-9a84-473f-8291-18d21630e795" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a3b1beb5-ef39-46c3-9cc0-3af7d9146ece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5d948d1f-bc7f-44e2-881b-1ff4b52f2c3f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a3b1beb5-ef39-46c3-9cc0-3af7d9146ece" xlink:to="loc_us-gaap_EquityComponentDomain_5d948d1f-bc7f-44e2-881b-1ff4b52f2c3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5d948d1f-bc7f-44e2-881b-1ff4b52f2c3f" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a3b1beb5-ef39-46c3-9cc0-3af7d9146ece" xlink:to="loc_us-gaap_EquityComponentDomain_5d948d1f-bc7f-44e2-881b-1ff4b52f2c3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_75539f24-68c0-4a77-b4f7-204d001af913" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5d948d1f-bc7f-44e2-881b-1ff4b52f2c3f" xlink:to="loc_us-gaap_CommonStockMember_75539f24-68c0-4a77-b4f7-204d001af913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TitleOfIndividualAxis_ff8d6f5c-d267-474c-b164-aebda1718f66" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf7e8e59-9a84-473f-8291-18d21630e795" xlink:to="loc_us-gaap_TitleOfIndividualAxis_ff8d6f5c-d267-474c-b164-aebda1718f66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_63dd2e1c-40ed-46e7-9f79-604bb214a395_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TitleOfIndividualAxis_ff8d6f5c-d267-474c-b164-aebda1718f66" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_63dd2e1c-40ed-46e7-9f79-604bb214a395_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_63dd2e1c-40ed-46e7-9f79-604bb214a395" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TitleOfIndividualAxis_ff8d6f5c-d267-474c-b164-aebda1718f66" xlink:to="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_63dd2e1c-40ed-46e7-9f79-604bb214a395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectorMember_d72a0a80-8e22-404f-b3c3-2bf1ee408e23" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TitleOfIndividualWithRelationshipToEntityDomain_63dd2e1c-40ed-46e7-9f79-604bb214a395" xlink:to="loc_us-gaap_DirectorMember_d72a0a80-8e22-404f-b3c3-2bf1ee408e23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e9835b38-b89a-413c-9f9f-51ad36c42a02" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bf7e8e59-9a84-473f-8291-18d21630e795" xlink:to="loc_us-gaap_AwardTypeAxis_e9835b38-b89a-413c-9f9f-51ad36c42a02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5f2ddab-ff9c-49a7-a7da-a04d66df158e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e9835b38-b89a-413c-9f9f-51ad36c42a02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5f2ddab-ff9c-49a7-a7da-a04d66df158e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5f2ddab-ff9c-49a7-a7da-a04d66df158e" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e9835b38-b89a-413c-9f9f-51ad36c42a02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5f2ddab-ff9c-49a7-a7da-a04d66df158e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_62283149-2352-4061-b719-17d3c278c640" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5f2ddab-ff9c-49a7-a7da-a04d66df158e" xlink:to="loc_us-gaap_RestrictedStockMember_62283149-2352-4061-b719-17d3c278c640" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:href="cpix-20180331.xsd#cpix_ShareholdersEquityTextualAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bab5ea3f-f87b-4314-b745-de41113dab1a" xlink:to="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_637db0e7-d1b8-4fb7-bc41-afff356925ce" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_637db0e7-d1b8-4fb7-bc41-afff356925ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_d13a9004-7988-4930-a2c2-f115f42fe9ac" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_d13a9004-7988-4930-a2c2-f115f42fe9ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_e8fca253-93d9-41fd-882c-bd837fda8085" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_e8fca253-93d9-41fd-882c-bd837fda8085" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleOfCorporateSecurities_fb682e75-84a0-40f1-8ce0-9ad405bffaed" xlink:href="cpix-20180331.xsd#cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleOfCorporateSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:to="loc_cpix_StockIssuedDuringPeriodShelfRegistrationProceedsFromSaleOfCorporateSecurities_fb682e75-84a0-40f1-8ce0-9ad405bffaed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e89b3960-a55b-4ef9-a50a-7b2cfa173010" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e89b3960-a55b-4ef9-a50a-7b2cfa173010" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_4009047e-322d-4d8b-bef5-e4bcce997159" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_4009047e-322d-4d8b-bef5-e4bcce997159" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a87adbf0-38d9-4553-b873-29296d30144c" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a87adbf0-38d9-4553-b873-29296d30144c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_490aa76a-b8ce-4f9c-b098-6dde78e6a909" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cpix_ShareholdersEquityTextualAbstract_cc1cedc4-6706-4e3c-89fd-9d7ab3b3c67c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_490aa76a-b8ce-4f9c-b098-6dde78e6a909" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#ShareholdersEquityandDebtDebtDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/ShareholdersEquityandDebtDebtDetails" xlink:type="extended" id="iab1e503869cb46bfb35916dee15d2feb_637c91c1-4fda-480d-9a86-2862454618ed">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_83c6d009-6928-4055-870b-d0086d89e3b0" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e3aaaf8f-1e68-4ae0-ace3-859bd5d6c12e" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_83c6d009-6928-4055-870b-d0086d89e3b0" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e3aaaf8f-1e68-4ae0-ace3-859bd5d6c12e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_6e2d9643-c585-444d-aec7-c10133b96579" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e3aaaf8f-1e68-4ae0-ace3-859bd5d6c12e" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_6e2d9643-c585-444d-aec7-c10133b96579" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_40df7bb5-6e3e-4686-ad09-fec7c6432564_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6e2d9643-c585-444d-aec7-c10133b96579" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_40df7bb5-6e3e-4686-ad09-fec7c6432564_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_40df7bb5-6e3e-4686-ad09-fec7c6432564" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_6e2d9643-c585-444d-aec7-c10133b96579" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_40df7bb5-6e3e-4686-ad09-fec7c6432564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_PinnacleBankMember_02a5d42b-5524-489b-88d7-108ed701aae4" xlink:href="cpix-20180331.xsd#cpix_PinnacleBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_40df7bb5-6e3e-4686-ad09-fec7c6432564" xlink:to="loc_cpix_PinnacleBankMember_02a5d42b-5524-489b-88d7-108ed701aae4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_SunTrustBankMember_590d5481-4133-4882-ad46-c83e070187d0" xlink:href="cpix-20180331.xsd#cpix_SunTrustBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_40df7bb5-6e3e-4686-ad09-fec7c6432564" xlink:to="loc_cpix_SunTrustBankMember_590d5481-4133-4882-ad46-c83e070187d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d7543798-78a3-4331-a3ab-1687f422dc97" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e3aaaf8f-1e68-4ae0-ace3-859bd5d6c12e" xlink:to="loc_us-gaap_DebtInstrumentAxis_d7543798-78a3-4331-a3ab-1687f422dc97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3b45619d-d303-43c6-8277-db026d3163d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d7543798-78a3-4331-a3ab-1687f422dc97" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3b45619d-d303-43c6-8277-db026d3163d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3b45619d-d303-43c6-8277-db026d3163d9" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d7543798-78a3-4331-a3ab-1687f422dc97" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3b45619d-d303-43c6-8277-db026d3163d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_eb2ad641-f853-40a6-bf2f-f7174b68392e" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3b45619d-d303-43c6-8277-db026d3163d9" xlink:to="loc_us-gaap_LineOfCreditMember_eb2ad641-f853-40a6-bf2f-f7174b68392e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_56971712-83aa-4e09-8f4c-6a317563759f" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e3aaaf8f-1e68-4ae0-ace3-859bd5d6c12e" xlink:to="loc_us-gaap_CreditFacilityAxis_56971712-83aa-4e09-8f4c-6a317563759f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d407a933-8f92-4ed6-aca6-341ad8933b35_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_56971712-83aa-4e09-8f4c-6a317563759f" xlink:to="loc_us-gaap_CreditFacilityDomain_d407a933-8f92-4ed6-aca6-341ad8933b35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d407a933-8f92-4ed6-aca6-341ad8933b35" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_56971712-83aa-4e09-8f4c-6a317563759f" xlink:to="loc_us-gaap_CreditFacilityDomain_d407a933-8f92-4ed6-aca6-341ad8933b35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b90a3405-d695-40db-991c-69188eeb69cf" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_d407a933-8f92-4ed6-aca6-341ad8933b35" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b90a3405-d695-40db-991c-69188eeb69cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RangeAxis_55b14deb-ada7-48a3-9601-6d4bc007c2bf" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e3aaaf8f-1e68-4ae0-ace3-859bd5d6c12e" xlink:to="loc_us-gaap_RangeAxis_55b14deb-ada7-48a3-9601-6d4bc007c2bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RangeMember_3bc64de0-7cf0-41af-924d-39031471118d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RangeAxis_55b14deb-ada7-48a3-9601-6d4bc007c2bf" xlink:to="loc_us-gaap_RangeMember_3bc64de0-7cf0-41af-924d-39031471118d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RangeMember_3bc64de0-7cf0-41af-924d-39031471118d" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RangeAxis_55b14deb-ada7-48a3-9601-6d4bc007c2bf" xlink:to="loc_us-gaap_RangeMember_3bc64de0-7cf0-41af-924d-39031471118d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinimumMember_444dda62-761d-4fbd-8a75-16c6e48a8b93" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_3bc64de0-7cf0-41af-924d-39031471118d" xlink:to="loc_us-gaap_MinimumMember_444dda62-761d-4fbd-8a75-16c6e48a8b93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumMember_15c3a472-4ee5-4964-ab0e-6960c1f3c1a5" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RangeMember_3bc64de0-7cf0-41af-924d-39031471118d" xlink:to="loc_us-gaap_MaximumMember_15c3a472-4ee5-4964-ab0e-6960c1f3c1a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions_5f5cd25a-141d-483e-b8fd-3cb07a2b930c" xlink:href="cpix-20180331.xsd#cpix_LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_83c6d009-6928-4055-870b-d0086d89e3b0" xlink:to="loc_cpix_LineOfCreditFacilityMaximumBorrowingCapacityUponSatisfactionOfCertainConditions_5f5cd25a-141d-483e-b8fd-3cb07a2b930c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_62059e05-e5a8-41fd-9737-44883dde720e" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_83c6d009-6928-4055-870b-d0086d89e3b0" xlink:to="loc_us-gaap_LineOfCreditFacilityExpirationPeriod_62059e05-e5a8-41fd-9737-44883dde720e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2b39946d-39f1-4644-b826-293c5a9c702e" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_83c6d009-6928-4055-870b-d0086d89e3b0" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2b39946d-39f1-4644-b826-293c5a9c702e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5e36c044-368f-473a-b895-8c3f4eb48eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_83c6d009-6928-4055-870b-d0086d89e3b0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5e36c044-368f-473a-b895-8c3f4eb48eb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_832ca96a-8b78-4ce5-8f63-6e2fff0bf5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_83c6d009-6928-4055-870b-d0086d89e3b0" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_832ca96a-8b78-4ce5-8f63-6e2fff0bf5e6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLineOfCredit_f51c0e03-11ab-4f91-8752-08bef8caabfb" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermLineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_83c6d009-6928-4055-870b-d0086d89e3b0" xlink:to="loc_us-gaap_LongTermLineOfCredit_f51c0e03-11ab-4f91-8752-08bef8caabfb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_62f97296-124b-45a6-ad15-3c5b56454b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_83c6d009-6928-4055-870b-d0086d89e3b0" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_62f97296-124b-45a6-ad15-3c5b56454b2a" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="cpix-20180331.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxes" xlink:type="extended" id="i6a69ba8298fa440884db0dd327698ef2_9a5afd4e-6997-4eca-b0b8-c340dc3879ef"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/IncomeTaxesTextualDetails" xlink:type="simple" xlink:href="cpix-20180331.xsd#IncomeTaxesTextualDetails"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/IncomeTaxesTextualDetails" xlink:type="extended" id="i375c3f61338b47d3b939b1c30ff8030d_1589c17f-5779-4c28-933c-6d5bbba33a87"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/CollaborativeAgreements" xlink:type="simple" xlink:href="cpix-20180331.xsd#CollaborativeAgreements"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/CollaborativeAgreements" xlink:type="extended" id="i0cce667459514da390e3768190374622_dbfb4645-7a5e-4c7c-9ced-a2216108d0ba"/>
  <link:roleRef roleURI="http://cumberlandpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cpix-20180331.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://cumberlandpharma.com/role/CommitmentsandContingencies" xlink:type="extended" id="id8ec85103d974af9b53622bf82b954f8_11ad5a5c-5ec2-4fc2-ba6a-b42c04cef41d"/>
</link:linkbase>
